Call us +49 (0)761 / 270-51190

Gan J, Pinto-Fernández A, Flierman D, Akkermans JJLL, O’Brien DP, Greenwood H, Scott HC, Fritz G, Knobeloch K-P, Neefjes J, van Dam H, Ovaa H, Ploegh HL, Kessler BM, Geurink PP, Sapmaz A: USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism. Proc Natl Acad Sci U S A 120(50):e2315163120. doi: 10.1073/pnas.2315163120 (2023).

Sankowski R, Prinz M: Microglia out of place-mapping macrophages across the developing human body. Cell Mol Immunol; doi: 10.1038/s41423-023-01100-2 (2023).

Wang M, Dehlinger A, Fernández Zapata C, Golan M, Gallaccio G, Sander LE, Schlickeiser S, Kunkel D, Schmitz-Hübsch T, Sawitzki B, Karni A, Braun J, Loyal L, Thiel A, Bellmann-Strobl J, Paul F, Meyer-Arndt L, Chotima Böttcher: Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases . Nat Commun 14(1):7728; doi: 10.1038/s41467-023-43553-z (2023).

Caceres L, Abogunloko T, Malchow S, Ehret F, Merz J, Li X, Sol Mitre L, Magnani N, Tasat D, Mwinyella T, Spiga L, Suchanek D, Fischer L, Gorka O, Colin Gissler M, Hilgendorf I, Stachon P, Rog-Zielinska E, Groß O, Westermann D, Evelson P, Wolf D, Marchini T: Molecular mechanisms underlying NLRP3 inflammasome activation and IL-1β production in air pollution fine particulatematter (PM2.5)-primed macrophages. Environ Pollut 122997. doi: 10.1016/j.envpol.2023.122997 (2023).

Wogram E, Prinz M: APOE set the microglia free. Nat Immunol 24(11):1790-1791; doi: 10.1038/s41590-023-01651-6 (2023).

Zaiss D.M.W., E.J. Pearce, D. Artis, A.N.J. McKenzie, and C.S.N. Klose. 2023. Cooperation of ILC2s and Th2 cells in the expulsion of intestinal helminth parasites. Nature Reviews Immunology; 10.1038/s41577-023-00942-1.

Faust TE, Feinberg PA, O’Connor C, Kawaguchi R, Chan A, Strasburger H, Frosch M, Boyle MA, Masuda T, Amann L, Knobeloch K-P, Prinz M, Schaefer A, Schafer DP: A comparative analysis of microglial inducible Cre lines. Cell Rep 42(9):113031; doi: 10.1016/j.celrep.2023.113031 (2023).

Lauer EM, Riegler E, Mutter JA, Alig SK, Bleul S, Kuehn J, Ranganathan L, Klingler C, Demerath T, Würtemberger U, Rau A, Weiß J, Eisenblaetter M, Bamberg F, Prinz M, Finke J, Duyster J, Illerhaus G, Diehn M, Alizadeh AA, Schorb E, Reinacher PC, and Scherer F: Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas. Neuro Oncol noad177; doi: 10.1093/neuonc/noad177 (2023).

Eisenbeis VB, Qiu D, Gorka O, Strotmann L, Liu G, Prucker I, Su XB, Wilson MSC, Ritter K, Loenarz C, Groß O, Saiardi A, Jessen HJ: β-lapachone regulates mammalian inositol pyrophosphate levels in an NQO1- and oxygen-dependent manner. Proc Natl Acad Sci U S A 120(34):e2306868120. doi: 10.1073/pnas.2306868120 (2023).

Forde AJ, Kolter J, Zwicky P, Baasch S, Lohrmann F, Eckert M, Gres V, Lagies S, Gorka O, Rambold AS, Buescher JM, Kammerer B, Lachmann N, Prinz M, Groß O, Pearce EJ, Becher B, Henneke P: Metabolic rewiring tunes dermal macrophages in staphylococcal skin infection. Sci Immunol 8(86):eadg3517; doi: 10.1126/sciimmunol.adg3517 (2023).

Macpherson AJ, Pachnis V, Prinz M: Boundaries and integration between microbiota, the nervous system, and immunity. Immunity 56(8):1712-1726; doi: 10.1016/j.immuni.2023.07.011 (2023).

Apostolova P, Kreutmair S, Toffalori C, Punta M, Unger S, Burk A-C, Wehr C, Maas-Bauer K, Melchinger W, Haring E, Hoefflin R, Shoumariyeh K, Hupfer V, Lauer EM, Duquesne S, Lowinus T, Núñez NG, Alberti C, da Costa Pereira S, Merten CH, […], Boerries M, […], Zeiser R: Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response. Br J Haematol; doi: 10.1111/bjh.19007 (2023).

Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Glück S, Thacker VV, Favre L, Mangeat B, Kroese LJ, Krimpenfort P, Prinz M, Ablasser A: cGAS-STING drives ageing-related inflammation and neurodegeneration . Nature 620(7973):374-380; doi: 10.1038/s41586-023-06373-1 (2023).

Langenbach M, Giesler S, Richtsfeld S, Costa-Pereira S, Rindlisbacher L, Wertheimer T, Braun LM, Andrieux G, Duquesne S, Pfeifer D, Woessner NM, Menssen HD, Taromi S, Duyster J, Börries M, Brummer T, Blazar BR, Minguet S, Turko P, Levesque MP, Becher B, Zeiser R: MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production. Mol Cancer Res 21(8):849-864; doi: 10.1158/1541-7786.MCR-22-0898 (2023).